Hopfner Robert Lorne
SEC Form 4 insider trading activity
Hopfner Robert Lorne has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Dec 22, 2025.
On the most recent filing, Hopfner Robert Lorne is listed as Director, 10% Owner at Evommune, Inc. Inside the rolling window, Hopfner Robert Lorne reported 1 open-market purchase totaling $17K in EVMN and no open-market sales.
Companies traded
Other insiders at EVMN
Insider Buying
$17K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hopfner Robert Lorne made?
Hopfner Robert Lorne has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Hopfner Robert Lorne trade?
Hopfner Robert Lorne has filed SEC Form 4 disclosures for 1 company, including EVMN.
When was Hopfner Robert Lorne's most recent SEC Form 4 filing?
Hopfner Robert Lorne's most recent SEC Form 4 filing on Tracefour is dated Dec 22, 2025.
What is Hopfner Robert Lorne's total buy and sell value in the current window?
Inside the rolling retention window, Hopfner Robert Lorne bought $17K and sold $0 based on SEC Form 4 filings.
What was Hopfner Robert Lorne's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,000 EVMN shares on 2025-12-19, worth $17K, per SEC Form 4 filings.